Aftab Dana 4

What Happened

• Aftab Dana, Executive Vice President, Research and Development at Exelixis, sold 29,873 shares of EXEL common stock in an open-market sale on February 19, 2026. The shares were sold at $44.35 per share for total proceeds of approximately $1,324,868. This was a sale (disposition), which is often routine and does not necessarily indicate a change in the insider’s view of the company.

Key Details

• Transaction date and price: 2026-02-19 — 29,873 shares sold at $44.35 each.
• Total value: ~$1,324,868.
• Transaction type/code: Open market sale (S).
• Shares owned after transaction: Not explicitly stated in the provided excerpt. The filing notes beneficial holdings that include (see footnotes below).
• Footnotes of note:
  • F1: Reporting person has 414,043 shares that will be issued upon vesting of RSUs and PSUs granted March 31, 2025 (RSUs = one-for-one economic equivalent; PSUs = contingent rights to receive shares).
  • F2: Represents shares held under the Exelixis 401(k) Plan as of Feb 18, 2026.
• Filing/timeliness: Form 4 filed on 2026-02-23 for the 2026-02-19 transaction — appears timely (filed within required SEC timeframe).

Context

• Sales by executives can be for many personal or tax reasons; they are common and not inherently a negative signal. Because this filing shows a straight open-market sale (not an option exercise or gift), it represents a cash disposition of existing shares.
• The filing does not indicate a 10% owner or other control change, and no 10b5-1 trading plan or tax-withholding notation is provided in the excerpt.